Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- survival and death patients after follow-up investigation for 60 months
研究概览
简要总结
The investigators retrospectively reviewed the electronic medical records of the patients with spontaneous cerebral hemorrhage and mechanical valves from 2015 to 2020 in the second affiliated hospital of Zhejiang university medical college. Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with spontaneous cerebral hemorrhage and mechanical valves
排除标准
- •pregnant patients
- •death in 24 hours without anticoagulant
研究组 & 干预措施
thromboembolism
干预措施: Low molecular weight heparin (Drug)
no thromboembolism and cerebral hemorrhage
干预措施: Low molecular weight heparin (Drug)
cerebral hemorrhage
干预措施: Low molecular weight heparin (Drug)
结局指标
主要结局
survival and death patients after follow-up investigation for 60 months
时间窗: 2015-2020
the patients with spontaneous cerebral hemorrhage and mechanical valves in the second affiliated hospital of Zhejiang university medical college.
次要结局
未报告次要终点